Rectal-specific microbicide applicator: Evaluation and comparison with a vaginal applicator used rectally

AIDS and Behavior

Volumn 18, Issue 9, 2014, Pages 1734-1745

  Carballo Diéguez, Alex ^a   Giguere, Rebecca ^a   Dolezal, Curtis ^a   Bauermeister, José ^b   Leu, Cheng Shiun ^a   Valladares, Juan ^a   Rohan, Lisa C ^c   Anton, Peter A ^d   Cranston, Ross D ^e   Febo, Irma ^f   Mayer, Kenneth ^g   McGowan, Ian ^h  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^g FENWAY INSTITUTE   (United States)

^h UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Acceptability; Applicators; Delivery systems; HIV prevention; Puerto Rico; Rectal microbicides; USA; Young MSM

Indexed keywords

GEL; TOPICAL ANTIINFECTIVE AGENT;

DEVICES; DRUG DELIVERY SYSTEM; EVALUATION STUDY; GEL; HIV INFECTIONS; HUMAN; INTERVIEW; INTRAVAGINAL DRUG ADMINISTRATION; MALE; MALE HOMOSEXUALITY; PATIENT ATTITUDE; PROCEDURES; PSYCHOLOGY; PUERTO RICO; QUALITATIVE RESEARCH; RECTAL DRUG ADMINISTRATION; SOCIOECONOMICS; UNITED STATES;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, RECTAL; ANTI-INFECTIVE AGENTS, LOCAL; BOSTON; DRUG DELIVERY SYSTEMS; GELS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INTERVIEWS AS TOPIC; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PENNSYLVANIA; PUERTO RICO; QUALITATIVE RESEARCH; SOCIOECONOMIC FACTORS;

EID: 84906320274     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-014-0793-0     Document Type: Article

References (17)

1. Carballo-Diéguez A, Stein Z, Sáez H, Dolezal C, Nieves-Rosa L, Díaz F. Frequent use of lubricants for anal sex among men who have sex with men: the HIV prevention potential of a microbicidal gel. Am J Public Health. 2000;90(7):1117-21.
2. Gorbach PM, Weiss RE, Fuchs E, Jeffries RA, Hezerah M, Brown S, et al. The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk. Sex Transm Dis. 2012;39(1):59-64.
3. Javanbakht M, Murphy R, Gorbach P, LeBlanc M-A, Pickett J. Preference and practices relating to lubricant use during anal intercourse: implications for rectal microbicides. Sex Health. 2010;7(2):193-8.
4. Gross M, Celum CL, Tabet SR, Kelly CW, Coletti AS, Chesney MA. Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide. Sex Transm Dis. 1999;26(10):572-8.
5. Anton PA, Saunders T, Elliott J, Khanukhova E, Dennis R, Adler A, et al. First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy. PLoS One. 2011;6(9):e23243.
6. Ventuneac A, Carballo-Diéguez A, McGowan I, Dennis R, Adler A, Khanukhova E, et al. Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men. AIDS Behav. 2010;14(3):618-28.
7. Pines HA, Gorbach PM, Weiss RE, Hess K, Murphy R, Saunders T, et al. Acceptability of potential rectal microbicide delivery systems for HIV prevention: a randomized crossover trial. AIDS Behav. 2013;17(3):1002-15.
8. Mabragaña M, Carballo-Diéguez A, Giguere R. Young women's experience with using videoconferencing for the assessment of sexual behavior and microbicide use. Telemed J E. 2013;19(11):866-71.
9. MacQueen KM, McLellan E, Kay K, Milstein B. Codebook development for team-based qualitative analysis. Cult Anthropol Methods. 1998;10(2):31-6.
10. NVivo qualitative data analysis software; QSR International Pty Ltd. Version 8. 2008.
11. Patton MQ. Qualitative research and evaluation methods. 3rd ed. Thousand Oaks: Sage; 2002.
12. Carballo-Diéguez A, Giguere R, Dolezal C, Bauermeister J, Leu C-S, Valladares J, Frasca T, Labbett R, Cranston RD, Febo I, Mayer K, McGowan I. Adherence to rectal gel use among mainly ethnic minority young men who have sex with men during a 3-month placebo gel trial: implications for microbicide research. AIDS Behav. 2014. doi: 10.1007/s10461-014-0768-1
13. McGowan I, Hoesley C, Cranston RD, Andrew P, Janocko L, Dai JY, et al. A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1 % gel (MTN-007). PLoS One. 2013;8(4):e60147.
14. Pfister HR, Böhm G. The multiplicity of emotions: a framework of emotional functions in decision making. Judgm Decis Mak. 2008;3(1):5-17.
15. Carballo-Diéguez A, Dolezal C, Bauermeister JA, O'Brien W, Ventuneac A, Mayer K. Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men. Sex Transm Infect. 2008;84(6):483-7.
16. Van der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B, Mathebula F, et al. Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLoS One. 2014;9(2):e89118.
17. Marrazzo J, Ramjee G, Nair G, Palanee T, Mkhize B, et al. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir emtricitabine, or vaginal tenofovir gel in the VOICE Study (MTN 003). Atlanta: Sage; 2013.